| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.31 | 0.004 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |